- Beat earnings estimates in 3 of the last 4 quarters
- Attractive free cash flow ratio of 3.0x
- Bullish trend confirmed on both short and long timeframes
Emergent Biosolutions Inc stock downgraded from Hold/Accumulate to Sell Candidate after Thursday trading session
(Updated on Jun 18, 2026)
The Emergent Biosolutions Inc stock price fell by -1.72% on the last day (Thursday, 18th Jun 2026) from $8.14 to $8.00. During the last trading day the stock fluctuated 5.38% from a day low at $7.90 to a day high of $8.32. The price has fallen in 7 of the last 10 days and is down by -5.21% for this period. Volume has increased on the last day by 780 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $12.80 million.
The stock is at the lower part of a wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $7.76 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Emergent Biosolutions Inc stock with a 90% probability to be traded between $7.89 and $9.74 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
EBS Signals & Forecast
A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 3.23%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Emergent Biosolutions Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.16 and $8.45. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Emergent Biosolutions Inc stock
Emergent Biosolutions Inc finds support from accumulated volume at $7.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.425 between high and low, or 5.38%. For the last week, the stock has had daily average volatility of 5.32%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (EBS) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Emergent Biosolutions Inc to open at $8.07, and during the day (based on 14 day Average True Range), to move between $7.77 and $8.23, which gives a possible trading interval of +/-$0.453 (+/-5.83%) up or down from last closing price. If Emergent Biosolutions Inc takes out the full calculated possible swing range there will be an estimated 5.83% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $7.95 (0.62%) than the resistance at $8.19 (2.37%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Emergent Biosolutions Inc stock A Buy?
Emergent Biosolutions Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.646
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on June 22, 2026 - $8.07 ( 0.90%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
EBS Performance
Trading levels for EBS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.50 | 6.21% |
| R2 | 8.33 | 4.18% |
| R1 | 8.23 | 2.93% |
| Price | 8.00 | |
| S1 | 7.91 | -1.13% |
| S2 | 7.81 | -2.39% |
| S3 | 7.65 | -4.42% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 8.23 | 2.88% |
| R2 | 8.21 | 2.63% |
| R1 | 8.19 | 2.37% |
| Price | 8.00 | |
| S1 | 7.95 | -0.625% |
| S2 | 7.93 | -0.88% |
| S3 | 7.75 | -3.13% |
FAQ
Click here for our free guide on how to buy Emergent Biosolutions Inc Stock.
Buy EBS